Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Human growth factor 20 can boost mouse whisker growth.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Baricitinib may help people with long-term alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A woman with lupus developed rare skin growths that went away on their own.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Fractional CO2 laser is more effective and safer than steroid injections for treating alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

There are various treatment options for frontal fibrosing alopecia.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

A woman with severe hair loss was successfully treated with the drug adalimumab.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.